Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001615774-17-001908
Filing Date
2017-04-28
Accepted
2017-04-28 09:10:59
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-1/A s105974_f1a.htm F-1/A 2785259
2 EXHIBIT 23.2 s105974_ex23-2.htm EX-23.2 2475
3 GRAPHIC logo_f1.jpg GRAPHIC 7712
4 GRAPHIC pg64img1_f1.jpg GRAPHIC 122283
5 GRAPHIC pg67img1_f1.jpg GRAPHIC 135537
6 GRAPHIC pg68img1_f1.jpg GRAPHIC 67786
7 GRAPHIC pg72img1_f1.jpg GRAPHIC 192345
8 GRAPHIC pg72img2_f1.jpg GRAPHIC 41039
9 GRAPHIC pg72img3_f1.jpg GRAPHIC 39412
10 GRAPHIC pg73img1_f1.jpg GRAPHIC 38716
11 GRAPHIC pg77img1_f1.jpg GRAPHIC 81822
12 GRAPHIC pg8img1_f1.jpg GRAPHIC 122283
  Complete submission text file 0001615774-17-001908.txt   3958976
Mailing Address PO BOX 8694 ARMADALE, VICTORIA C3 3143
Business Address PO BOX 8694 ARMADALE, VICTORIA C3 3143 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1/A | Act: 33 | File No.: 333-215204 | Film No.: 17791883
SIC: 2834 Pharmaceutical Preparations